BridgeMD
New treatment option for Hiv
Official title Making ART Work Among Brazilian Youth
ClinicalTrials.gov ID: NCT06056037
What this study is testing
- What it's testing
- This study seeks to develop and pilot test a theory-based, integrated technology and counseling intervention to improve ART adherence among sexual and gender minority (SGM) young people living with HIV (ages 18-24) in Rio de Janeiro, Brazil. The intervention aims to improve social support, self-efficacy for taking ART, and teach skills for problem-solving barriers to promote better adherence.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 24, men only
You may be able to join if
- between 18 and 24 years of age
- assigned male sex at birth
- identify as a gay or bisexual man, or a transgender woman or another gender identity along the feminine spectrum
- self-report living with HIV, and verified by medical chart review,
- self-report currently taking or prescribed ART for \> 3 months
You likely can't join if
- unable to give informed consent due to cognitive limitation, severe mental/physical illness or intoxication
- unable to read and/or write to an extent that would limit their ability to comprehend the informed consent
- lived in the greater Rio de Janeiro area for \< 3 months or planning to move outside the area within the next year
See the full eligibility criteria
- between 18 and 24 years of age
- assigned male sex at birth
- identify as a gay or bisexual man, or a transgender woman or another gender identity along the feminine spectrum
- self-report living with HIV, and verified by medical chart review,
- self-report currently taking or prescribed ART for \> 3 months
- self-report missing 2 or more doses of ART medications in any given week in the past month OR not virally suppressed (i.e., \>40 copies/mL in past 3 months; via national outpatient data [SISCEL] or plasma viral load...
- owns a cell phone or willing to use one as part of the study
- unable to give informed consent due to cognitive limitation, severe mental/physical illness or intoxication
- unable to read and/or write to an extent that would limit their ability to comprehend the informed consent
- lived in the greater Rio de Janeiro area for \< 3 months or planning to move outside the area within the next year
The study team makes the final eligibility decision.
Where it's taking place
- Rio de Janeiro, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 24 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rio de Janeiro, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.